The molecular profile of AML with trisomy 8 often includes mutations in DNMT3A, RUNX1, FLT3-ITD, IDH2, NPM1 and ASXL1, which can affect prognosis and therapeutic response [111]. Here, IDH2 is linked to acute myeloid leukemia.